Vitaspring Biomedical Co Stock Short Ratio
| VSBC Stock | USD 1.00 0.00 0.00% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess VitaSpring Biomedical's long-term financial health and intrinsic value.
VitaSpring |
VitaSpring Biomedical Co Company Short Ratio Analysis
VitaSpring Biomedical's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, VitaSpring Biomedical Co has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The short ratio for all United States stocks is 100.0% higher than that of the company.
VitaSpring Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses VitaSpring Biomedical's direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of VitaSpring Biomedical could also be used in its relative valuation, which is a method of valuing VitaSpring Biomedical by comparing valuation metrics of similar companies.VitaSpring Biomedical is currently under evaluation in short ratio category among its peers.
VitaSpring Fundamentals
| Return On Equity | 0.84 | |||
| Return On Asset | 0.41 | |||
| Profit Margin | 0.19 % | |||
| Operating Margin | 0.24 % | |||
| Current Valuation | 2.89 B | |||
| Shares Outstanding | 206.52 M | |||
| Shares Owned By Insiders | 58.70 % | |||
| Price To Book | 1,622 X | |||
| Price To Sales | 558.27 X | |||
| Revenue | 5.61 M | |||
| Gross Profit | 2.06 M | |||
| EBITDA | 1.49 M | |||
| Net Income | 1.26 M | |||
| Cash And Equivalents | 21.59 K | |||
| Total Debt | 375.5 K | |||
| Debt To Equity | 0.21 % | |||
| Current Ratio | 4.23 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | 84.81 K | |||
| Beta | 1.43 | |||
| Market Capitalization | 3.1 B | |||
| Total Asset | 3.6 M | |||
| Net Asset | 3.6 M |
About VitaSpring Biomedical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze VitaSpring Biomedical Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VitaSpring Biomedical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of VitaSpring Biomedical Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in VitaSpring Pink Sheet
VitaSpring Biomedical financial ratios help investors to determine whether VitaSpring Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in VitaSpring with respect to the benefits of owning VitaSpring Biomedical security.